Vingtdeux V - Search Results

1

AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo.

Domise M, Didier S, Marinangeli C, Zhao H, Chandakkar P, Buée L, Viollet B, Davies P, Marambaud P, Vingtdeux V. Domise M, et al. Among authors: vingtdeux v. Sci Rep. 2016 May 27;6:26758. doi: 10.1038/srep26758. Sci Rep. 2016. PMID: 27230293 Free PMC article.

2

AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, Marambaud P. Vingtdeux V, et al. J Biol Chem. 2010 Mar 19;285(12):9100-13. doi: 10.1074/jbc.M109.060061. Epub 2010 Jan 14. J Biol Chem. 2010. PMID: 20080969 Free PMC article.

3

AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.

Vingtdeux V, Davies P, Dickson DW, Marambaud P. Vingtdeux V, et al. Acta Neuropathol. 2011 Mar;121(3):337-49. doi: 10.1007/s00401-010-0759-x. Epub 2010 Oct 19. Acta Neuropathol. 2011. PMID: 20957377 Free PMC article.

4

Small-molecule activators of AMP-activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis.

Vingtdeux V, Chandakkar P, Zhao H, Davies P, Marambaud P. Vingtdeux V, et al. Mol Med. 2011 Sep-Oct;17(9-10):1022-30. doi: 10.2119/molmed.2011.00163. Epub 2011 Jun 1. Mol Med. 2011. PMID: 21647536 Free PMC article.

5

Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.

Ma T, Chen Y, Vingtdeux V, Zhao H, Viollet B, Marambaud P, Klann E. Ma T, et al. Among authors: vingtdeux v. J Neurosci. 2014 Sep 3;34(36):12230-8. doi: 10.1523/JNEUROSCI.1694-14.2014. J Neurosci. 2014. PMID: 25186765 Free PMC article.

6

CALHM1 deficiency impairs cerebral neuron activity and memory flexibility in mice.

Vingtdeux V, Chang EH, Frattini SA, Zhao H, Chandakkar P, Adrien L, Strohl JJ, Gibson EL, Ohmoto M, Matsumoto I, Huerta PT, Marambaud P. Vingtdeux V, et al. Sci Rep. 2016 Apr 12;6:24250. doi: 10.1038/srep24250. Sci Rep. 2016. PMID: 27066908 Free PMC article.

7

AMPK in Neurodegenerative Diseases.

Domise M, Vingtdeux V. Domise M, et al. Among authors: vingtdeux v. Exp Suppl. 2016;107:153-177. doi: 10.1007/978-3-319-43589-3_7. Exp Suppl. 2016. PMID: 27812980 Review.

8

AMP-activated Protein Kinase Controls Immediate Early Genes Expression Following Synaptic Activation Through the PKA/CREB Pathway.

Didier S, Sauvé F, Domise M, Buée L, Marinangeli C, Vingtdeux V. Didier S, et al. Among authors: vingtdeux v. Int J Mol Sci. 2018 Nov 22;19(12):3716. doi: 10.3390/ijms19123716. Int J Mol Sci. 2018. PMID: 30467274 Free PMC article.

9

Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process.

Domise M, Sauvé F, Didier S, Caillerez R, Bégard S, Carrier S, Colin M, Marinangeli C, Buée L, Vingtdeux V. Domise M, et al. Among authors: vingtdeux v. Cell Death Dis. 2019 Mar 4;10(3):221. doi: 10.1038/s41419-019-1464-x. Cell Death Dis. 2019. PMID: 30833547 Free PMC article.

10

AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives.

Marinangeli C, Didier S, Vingtdeux V. Marinangeli C, et al. Among authors: vingtdeux v. Curr Drug Targets. 2016;17(8):890-907. doi: 10.2174/1389450117666160201105645. Curr Drug Targets. 2016. PMID: 26073858 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters